Is Medical Dosimetrist Certification Board Legit?

The Medical Dosimetrist Certification Board (MDCB) demonstrates consistent financial health, with revenues steadily exceeding expenses over the past decade. In the latest filing (202309), the organization reported revenues of $1,230,762 against expenses of $860,307, resulting in a surplus that contributes to its growing asset base, which stood at $4,183,834. This consistent surplus indicates sound financial management and the ability to build reserves. The organization's spending efficiency appears strong, particularly given the reported 0% officer compensation across all available filings. This suggests that the MDCB is effectively utilizing its resources for its mission without significant overhead tied to executive salaries. The absence of officer compensation also points to a high degree of volunteer leadership or a compensation structure that is not reported as officer compensation on the 990, which warrants further investigation for complete transparency. Transparency is generally good, with consistent annual filings available. However, the lack of reported officer compensation, while potentially positive, could also indicate a need for more detailed disclosure on how leadership is compensated, if at all, to fully understand the organization's operational costs. The consistent growth in assets and low liabilities across all periods further reinforces a picture of financial stability and responsible stewardship.